We have now extended these studies to the lymphoid system where ectopic Runx expression has been shown to be potently oncogenic in combination with other cancer gene lesions including p53 loss and Myc over‐expression [Vaillant et al., 1999; Blyth et al., 2001, 2006; Shimizu et al., 2013]. This evidence concerns the gene TP53 and cancer.